Questions
ghk cu cosmetic: Frequently asked questions
Source-derived answers connected to this topic. Only stored records are displayed.
What If I Accidentally Left My GHK-Cu Vial Out Overnight?
If the vial sat at room temperature (20–25°C) for more than four hours, peptide integrity is compromised. Copper-peptide bonds begin hydrolyzing at temperatures above 8°C, and the rate doubles every 10°C increase. An overnight excursion (8–12 hours) at ambient temperature likely degraded 40–60% of the active peptide. Refrigerating it afterward does not reverse this damage. Replace the vial rather than risk applying denatured product. Degraded peptides can trigger localised inflammation without delivering collagen synthesis benefits.
What If My Serum Copper Is Elevated Post-Treatment?
Serum copper >140 µg/dL after starting GHK-Cu suggests copper overload. Either from excessive dosing or pre-existing copper accumulation undetected at baseline. Copper overload triggers oxidative stress and accelerates skin aging rather than reversing it. Immediate action: reduce GHK-Cu dose by 50%, supplement zinc at 25–50 mg/day, and recheck copper and ceruloplasmin in 3 weeks. If serum copper remains >150 µg/dL, discontinue GHK-Cu temporarily and evaluate for Wilson's disease or other copper metabolism disorders.
What If My hsCRP Didn't Drop After 12 Weeks of GHK-Cu?
Stable or rising hsCRP despite consistent GHK-Cu use indicates inadequate dosing, poor absorption, or a concurrent inflammatory process overwhelming the peptide's anti-inflammatory capacity. Subcutaneous GHK-Cu at 1–2 mg/day should reduce hsCRP in patients with baseline elevations >2.0 mg/L within 8 weeks. If no reduction occurs, increase dose by 30% and verify injection technique. Shallow subcutaneous injections deposit peptide in adipose tissue where absorption is unpredictable. Alternatively, rule out undiagnosed inflammatory conditions (autoimmune disease, chronic infection, metabolic syndrome) that require treatment beyond peptide therapy.
What If My Post-Treatment Ceruloplasmin Is Higher Than Baseline?
Elevated ceruloplasmin (>60 mg/dL) post-treatment suggests one of two things: therapeutic copper delivery to tissues (expected response) or acute-phase inflammatory reaction (pathological). Distinguish between them by checking hsCRP simultaneously. If hsCRP dropped and ceruloplasmin rose, the elevation is therapeutic. Copper is being mobilised for tissue repair. If both hsCRP and ceruloplasmin rose, the elevation signals inflammation unrelated to GHK-Cu. Persistent ceruloplasmin >70 mg/dL warrants adding zinc (25–50 mg/day elemental) to balance copper-zinc ratio and rechecking labs in 4 weeks.